Wuzhou Medical (301234.SZ) plans to purchase 100% of Xuanzhi Technology's shares to enter the field of motor control chips

According to Zhitong Finance App, Wuzhou Healthcare (301234.SZ) announced that the company plans to purchase 100% of Xuanzhi Technology's shares held by 34 counterparties including Liu Gang by issuing shares and paying cash, and to raise supporting capital by issuing shares to no more than 35 specific investors. The target company focuses on R&D, design and sales of highly integrated motor control chips, and is committed to providing “chip+algorithm+system” full-stack motor control solutions from chip design to system application. The target company has been deeply involved in the field of motor control chips for many years, and has deep experience in chip design and algorithm development. With continuous technological innovation and breakthroughs, the products have been widely used in various fields such as emerging intelligent equipment, white goods, industrial control, and automotive electronics.

After the transaction is completed, the listed company will enter the field of motor control chips, seek a second growth curve, accelerate the transformation to new quality productivity, and create new profit growth points. At the same time, listed companies can spread operating risks, reduce dependence on a single business or market, and help improve the level of steady operation.

At the same time, listed companies will introduce some investment institutions mainly focusing on the semiconductor sector, which is conducive to optimizing shareholder structures, using their industrial resources and investment experience in the semiconductor field, improving the efficiency of mergers and acquisitions integration and post-investment management capabilities, reducing the risk of cross-industry integration, and laying a solid foundation for the continuous and steady development of listed companies' semiconductor business.

According to the relevant regulations of the Shenzhen Stock Exchange, trading of the company's shares will resume with the opening of the market on July 22, 2026 upon application by the company.